Roche is narrowing its pipeline to 11 disease areas and continuing to invest in a targeted way, said Teresa Graham, chief ...

Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...

While the pandemic has been the focus of R&D attention for much of 2020, that is slowly beginning to shift towards other projects in the big pharma pipeline. pharmaphorum’s news editor ...

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Urogen Pharma (URGN – Research Report), with a ...

New York, USA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Breast Cancer Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...

Circle Pharma’s MXMO™ platform combines structure ... is currently in clinical trials as part of a growing pipeline of novel macrocycle therapeutics. For more information, visit ...

Ionis Pharmaceuticals (NASDAQ ... catalysts that could significantly impact Ionis' future trajectory. Ionis' pipeline is rich with potential, featuring several candidates in late-stage development ...

Quell Therapeutics Ltd (“Quell” or “the Company”), and eXmoor pharma (“eXmoor”), announce a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell ...

Roche ROG-0.08%decrease; red down pointing triangle Holding is narrowing the diseases it targets with its pharmaceutical research and development activities, betting on a slimmed-down approach as ...

Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX), a leading biotechnology company, has been making significant strides in expanding its pipeline beyond its core cystic fibrosis (CF ...